Unveiling the causal effects of phosphatidylethanolamine (18:1_0:0) via glutamine conjugate of C6H10O2 (2) and X-23648 in Parkinson’s disease: insights from mediation Mendelian randomization by Cyrus Huneycutt | Sep 1, 2025 | 0 comments Submit a Comment Cancel replyYou must be logged in to post a comment.
Recent Comments